A Randomized, Double-Blind, Active- and Placebo-Controlled, Single-Dummy, 4-Way Crossover Study to Determine the Abuse Potential of Pitolisant Compared to Phentermine and Placebo, in Healthy, Non-Dependent Recreational Stimulant Users
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2018
At a glance
- Drugs Pitolisant (Primary) ; Phentermine
- Indications Drug abuse
- Focus Therapeutic Use
- 27 Sep 2018 According to Harmony Biosciences media release, data from this study will be presented at the 24th Congress of the European Sleep Research Society (ESRS).
- 09 Nov 2017 Status changed from recruiting to completed.
- 16 May 2017 New trial record